The WCM COVID-19 Biobank is a collaborative initiative to process, store, and track biospecimens gathered for COVID-19 research at Weill Cornell Medicine. The purpose of this resource is to enable clinical and translational research on SARS-CoV-2 using biospecimens managed by the WCM Institutional Biorepository Core (IBC) in coordination with WCM faculty. The COVID-19 Biobank provides investigators with access to well-characterized samples and clinical data from patients who underwent COVID-19 testing at Weill Cornell Medicine outpatient clinics, NewYork-Presbyterian/Weill Cornell Medical Center’s E 68th St campus, and Lower Manhattan Hospital. In the future, specimens from other NYP campuses may be available.
Biospecimens for research are available upon request. For more information on specimen availability and the biospecimen request process, please view our SharePoint site.